Screener
Wave Life Sciences WVE Total Non-Current Assets
Total Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:AssetsNoncurrent.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 39,498 | 12,458 |
| Restricted cash | 3,815 | 3,806 |
| Other assets | 667 | 16 |
| Total long-term assets | 50,813 | 23,685 |
| Total assets | $558,321 | $638,499 |
| Liabilities, Series A preferred shares, and shareholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $20,362 | $15,700 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's total non-current assets?
- Wave Life Sciences (WVE) reported total non-current assets of $50.81M in Q2 2026.
- How has Wave Life Sciences's total non-current assets changed year-over-year?
- Wave Life Sciences's total non-current assets increased by 76.4% year-over-year, from $28.8M to $50.81M.
- What is the long-term trend for Wave Life Sciences's total non-current assets?
- Over 5 years (2020 to 2025), Wave Life Sciences's total non-current assets has grown at a -13.6% compound annual growth rate (CAGR), from $49.2M to $23.69M.
- What does total non-current assets mean?
- All long-term assets with useful lives beyond one year — equivalent to total_non_current_assets.
Ask your AI about Wave Life Sciences's total non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude